# DEXTROSE

NDC: 0338-0017
Generic name: DEXTROSE MONOHYDRATE
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 19710304

FDA application: NDA016673

## Active ingredients

- DEXTROSE MONOHYDRATE: 50 g/1000mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0338-0017"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0338-0017
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5